TABLE 2.

Primary and Secondary End Points

SMA DischargeYear 1PYear 2PYear 3P
A1C
 Patients evaluated (n)71697131
 Mean A1C (% [mmol/mol] ± SD)8.50 (69) ± 1.368.65 (71) ± 1.610.43*8.87 (73) ± 1.880.12*8.92 (74) ± 2.120.64*
 Patients meeting A1C goal <9% (% [n])66.2 (47)58.0 (40)0.4160.6 (43)0.0048.4 (15)1.00
 Patients meeting A1C goal <7% (% [n])12.7 (9)15.9 (11)0.7512.7 (9)1.0016.1 (5)0.38
Blood pressure
 Patients evaluated (n)71707133
 Mean SBP ± SD (mmHg)135.75 ± 17.49133.16 ± 16.030.22*136.70 ± 18.290.64*128.97 ± 12.630.03*
 Mean DBP ± SD (mmHg)79.62 ± 11.9076.03 ± 10.530.01*76.79 ± 11.840.04*75.42 ± 9.230.01*
 Patients meeting blood pressure goal <140/90 mmHg (% [n])57.7 (41)70.0 (49)0.1760.6 (43)0.8569.7 (23)0.27
Cholesterol
 Patients evaluated (n)71676424
 Mean LDL in mg/dL (mmol/L) ± SD79.73 (2.07) ± 24.2281.96 (2.12) ± 27.860.56*85.30 (2.21) ± 3.750.22*88.58 (2.29) ± 35.890.82*
 Patients meeting LDL goal <100 mg/dL (% [n])78.9 (56)74.6 (50)0.7764.1 (46)0.0670.8 (17)1.00
 Patients on moderate- or high-intensity statin (% [n])73.2 (52)74.6 (50)1.0076.6 (49)0.5883.3 (20)0.45
  • * Continuous variables were evaluated using the Student t test for paired samples, based on clinic discharge versus yearly follow-up data.

  • P values were derived from the McNemar test, based on clinic discharge versus yearly follow-up data.